Professor University of Toronto Toronto, Ontario, Canada
AI is revolutionizing the way we work across various industries, with some sectors adopting it more swiftly than others. In the realm of developing lifesaving medicines, precision is paramount, and nothing can be left to chance. As novel AI methodologies evolve daily, it prompts us to ask critical questions: Can AI maintain its pace in pharmaceutical product development? What changes are occurring, and what will remain constant? How can scientists keep up with this dynamic landscape? AI is enabling more innovative drug delivery approaches, patient-centric drug development, and precision medicine. Additionally, will regulatory pathways adapt to these advancements? Four distinguished speakers proposed will explore AI's application in excipient and formulation development, aiming to answer these questions and provide guidance on how the design and use of excipients are evolving due to AI advancements.
Learning Objectives:
Have a a guide for how the use of excipients is evolving due to advancement in AI.
Keep up with the changing landscape with advances in AI. the audience will know better how to harness AI to transform the development
Identify and address the limitations in the current use of AI for developing novel excipients, optimizing formulations and dosage forms for specific APIs
